Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths



  • Early on in the COVID-19 pandemic, doctors around the world reported high success rates using an inexpensive treatment protocol of hydroxychloroquine (HCQ) and zinc, typically in combination with an antibiotic to treat secondary bacterial infections
  • A medical review in the January 2021 issue of The American Journal of Medicine now urges early use of HCQ and zinc to reduce hospitalizations and deaths from COVID-19
  • HCQ is a zinc ionophore, meaning it shuttles zinc into the cell, and there’s compelling evidence to suggest the primary benefit of the HCQ protocol actually comes from the zinc, which effectively inhibits viral replication
  • For patients with cardinal features of COVID-19 (fever, body aches, nasal congestion, loss of taste and smell) at-home treatment can be the same as those with confirmed COVID-19, the authors say
  • While media headlines have painted HCQ as a life-threatening drug, it actually has a very robust safety profile that goes back decades

Continue reading